{'fraction_non_alphanumeric': 0.016574585635359115, 'fraction_numerical': 0.0, 'mean_word_length': 5.971153846153846, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Nonsteroidal anti-inflammatory agents in cataract intraocular lens surgery.

In recent years various well-controlled, prospective trials using several clinical parameters have shown nonsteroidal eye drops to be effective in treating postimplantation surgical inflammation. The efficacy of nonsteroidal drugs, however, is influenced by several factors such as the patient's race and other criteria. For this reason, further randomized clinical trials with a larger number of cases are necessary to determine the effectiveness of nonsteroidal eye drops compared with steroids. The effects of nonsteroidal agents in preventing intraoperative miosis and treating chronic cystoid macular edema are still especially controversial.